[1]是子豪,赖苏奇,乔 旦,等.炎症性肠病营养风险和营养治疗方案选择的回顾性研究[J].医学信息,2021,34(24):90-92.[doi:10.3969/j.issn.1006-1959.2021.24.020]
　SHI Zi-hao,LAI Su-qi,QIAO Dan,et al.Retrospective Study on Nutritional Risk and Nutritional Treatment Options of Inflammatory Bowel Disease[J].Medical Information,2021,34(24):90-92.[doi:10.3969/j.issn.1006-1959.2021.24.020]
点击复制

炎症性肠病营养风险和营养治疗方案选择的回顾性研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年24期
页码:
90-92
栏目:
论著
出版日期:
2021-12-15

文章信息/Info

Title:
Retrospective Study on Nutritional Risk and Nutritional Treatment Options of Inflammatory Bowel Disease
文章编号:
1006-1959（2021）24-0090-03
作者:
是子豪; 赖苏奇; 乔 旦; 等
（无锡市人民医院临床营养科，江苏 无锡 214000）
Author(s):
SHI Zi-hao; LAI Su-qi; QIAO Dan; et al.
(Department of Clinical Nutrition,Wuxi People’s Hospital,Wuxi 214000,Jiangsu,China)
关键词:
炎症性肠病; 营养风险; 营养治疗
Keywords:
Inflammatory bowel disease; Nutritional risk; Nutrition therapy
分类号:
R574
DOI:
10.3969/j.issn.1006-1959.2021.24.020
文献标志码:
A
摘要:
目的 研究炎症性肠病营养风险和营养治疗方案的选择。方法 回顾性分析2020年1月-2021年1月期间在我院诊治的74例炎症性肠病患者临床资料，分析炎症性肠病营养风险总发生率、溃疡性结肠炎（UC）和克罗恩病（CD）营养风险发生率、UC和CD营养风险相关因素以及营养治疗方案的选择。结果 74例患者营养风险总发生率为48.65%。74例炎症性肠病患者中UC患者58例，CD患者16例，UC患者营养风险发生率为44.83%，低于CD患者的62.50%（P＜0.05）。UC和CD患者BMI降低者营养风险发生率均高于BMI正常者和BMI增高者（P＜0.05）。有无营养风险的炎症性肠病患者在年龄、性别、炎症性肠病家族史上差异无统计学意义（P＞0.05）。UC慢性持续型复发、广泛受累、重度活动患者营养风险发生率较高（P＜0.05），CD穿透型、有手术史、重度活动患者营养风险发生率高（P＜0.05）。采用充足热卡营养治疗，CD治疗有效率为75.00%，高于UC患者的46.55%（P＜0.05）。结论 炎症性肠病患者营养风险较高，CD患者显著高于UC患者，尤其是BMI降低患者应更为重视。UC和CD患者营养风险具有各自的相关因素，临床在准确把握适应症、禁忌证的前提下，给予炎症性肠病患者给予肠内营养治疗是安全、可行的。
Abstract:
Objective To study the nutritional risk and nutritional treatment options of inflammatory bowel disease.Methods The clinical data of 74 patients with inflammatory bowel disease treated in our hospital from January 2020 to January 2021 were retrospectively analyzed. The total incidence of nutritional risk of inflammatory bowel disease, the incidence of nutritional risk of ulcerative colitis (UC) and Crohn’ s disease (CD), the related factors of nutritional risk of UC and CD and the selection of nutritional treatment options were analyzed.Results The total incidence of nutritional risk in 74 patients was 48.65%. Among the 74 patients with inflammatory bowel disease, 58 patients were UC and 16 patients were CD. The incidence of nutritional risk in UC patients was 44.83%, which was lower than 62.50% in CD patients (P<0.05). The incidence of nutritional risk in patients with lower BMI in UC and CD was higher than that in patients with normal BMI and higher BMI (P<0.05). There was no significant difference in age, gender and family history of inflammatory bowel disease between patients with and without nutritional risk (P>0.05). The incidence of nutritional risk in patients with chronic persistent recurrence, extensive involvement and severe activity of UC was high (P<0.05), and the incidence of nutritional risk in patients with CD penetration, surgical history and severe activity was high (P<0.05). The effective rate of CD treatment was 75.00%, which was higher than 46.55% of UC patients (P<0.05).Conclusion The nutritional risk of inflammatory bowel disease is high, and CD patients are significantly higher than UC patients, especially those with lower BMI should be paid more attention. The nutritional risk of UC and CD patients has their own related factors. Under the premise of accurately grasping the indications and contraindications, it is safe and feasible to give enteral nutrition therapy to patients with inflammatory bowel disease.

参考文献/References:

[1]Ng SC,Zeng Z,Niewiadomski O,et al.Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia[J].Gastroenterology,2016,150(1):86-95.[2]田雨,王化虹,李俊霞,等.炎症性肠病营养风险和营养治疗方案选择的回顾性分析[J].肠外与肠内营养,2018,25(2):98-101,106.[3]武芸,何瑶,陈芳,等.克罗恩病病人的营养风险筛查[J].中华医学杂志,2016,96(6):442-446.[4]中华医学会消化病学分会炎症性肠病学组,中华医学会肠外与肠内营养学分会胃肠病与营养协作组.炎症性肠病营养支持治疗专家共识（第二版）[J].中华炎性肠病杂志,2018,2(3):154-172.[5]Casanova MJ,Chaparro M,Molina B,et al.Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease[J].J Crohns Colitis,2017,11(12):1430-1439.[6]乔宇琪,冉志华.2016年欧洲临床营养与代谢学会炎症性肠病临床营养指南解读[J].中国实用内科杂志,2018,38(3):209-212.[7]Takaoka A,Sasaki M,Nakanishi N,et al.Nutritional Screening and Clinical Outcome in Hospitalized Patients with Crohn’s Disease[J].Ann Nutr Metab,2017,71(3-4):266-272.[8]王威.炎症性肠病的营养支持治疗方案回顾与疗效分析[J].中国现代药物应用,2019,13(23):49-50.[9]施嫣红,刘占举.炎症性肠病的肠内、肠外营养[J].临床内科杂志,2019,36(2):88-90.[10]Gomollón F,Gargallo CJ,Munoz JF,et al.Oral Cyanocobalamin is Effective in the Treatment of Vitamin B12 Deficiency in Crohn’s Disease[J].Nutrients,2017,9(3):E308.[11]魏天桐,王卉,高媛,等.北京大学第一医院消化内科2015年住院患者营养风险筛查和营养支持调查[J].实用预防医学,2017,24(4):41-44.[12]杨俊,秦环龙.炎症性肠病患者围手术期营养治疗策略[J].中华结直肠疾病电子杂志,2017,6(4):290-293.[13]赵美华,李林静,马娜,等.炎症性肠病与肠内、肠外营养[J].医学新知杂志,2017,27(4):330-333.[14]孙晋洁,孙永强.炎症性肠病患者营养认知行为调查与营养不良分析[J].实用临床医药杂志,2020,24(2):83-84.[15]田字彬,丁雪丽,荆雪.克罗恩病的营养评估及营养支持治疗[J].肠外与肠内营养,2019,26(9):257-258.[16]兰平,胡品津,朱维铭.炎性肠病术后并发症危险因素及预防的专家意见[J].中华胃肠外科杂志,2016,18(4):388-394.[17]范筱.探讨肠内外营养对炎症性肠病的治疗价值[J].中国实用医刊,2016,43(1):34-35.[18]彭健,曹竣植,张勇.不同营养干预方法对炎症性肠病患者的治疗效果和营养状态的影响[J].海南医学,2020,10(7):903-904.[19]吴启荣,关敏霞.早期肠内营养与肠外营养在炎症性肠病中的应用疗效比较[J].心电图杂志,2019,8(4):168-169.[20]肖琳,杨坚.肠内营养与肠外营养在炎症性肠病治疗中的应用价值分析[J].世界临床医学,2017,11(2):9.

相似文献/References:

[1]王莹洁,戴迟兵.益生菌在炎症性肠病中的应用研究[J].医学信息,2020,33(22):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
　WANG Ying-jie,DAI Chi-bing.Study on the Application of Probiotics in Inflammatory Bowel Disease[J].Medical Information,2020,33(24):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
[2]赖璐华,李玉兰.营养风险筛查在住院2型糖尿病患者中的应用[J].医学信息,2021,34(01):46.[doi:10.3969/j.issn.1006-1959.2021.01.013]
　LAI Lu-hua,LI Yu-lan.Application of Nutritional Risk Screening in Hospitalized Patients with Type 2 Diabetes[J].Medical Information,2021,34(24):46.[doi:10.3969/j.issn.1006-1959.2021.01.013]
[3]李剑鹏.老年肺结核营养风险及营养支持治疗研究[J].医学信息,2021,34(01):54.[doi:10.3969/j.issn.1006-1959.2021.01.015]
　LI Jian-peng.Study on Nutritional Risk and Nutritional Support Treatment of Elderly Pulmonary Tuberculosis[J].Medical Information,2021,34(24):54.[doi:10.3969/j.issn.1006-1959.2021.01.015]
[4]杨 蕾,敖丽娟.NUTRIC评分在危重症患者中的应用现状[J].医学信息,2021,34(07):35.[doi:10.3969/j.issn.1006-1959.2021.07.010]
　YANG Lei,AO Li-juan.Current Status of the Application of NUTRIC Score in Critically Ill Patients[J].Medical Information,2021,34(24):35.[doi:10.3969/j.issn.1006-1959.2021.07.010]
[5]邢 晗,杜美萱,马嘉泽,等.维生素在炎症性肠病中的研究[J].医学信息,2021,34(12):28.[doi:10.3969/j.issn.1006-1959.2021.12.008]
　XING Han,DU Mei-xuan,MA Jia-ze,et al.Research on Vitamins in Inflammatory Bowel Disease[J].Medical Information,2021,34(24):28.[doi:10.3969/j.issn.1006-1959.2021.12.008]
[6]邓雯懿,徐国玉,刘国辉.老年营养风险指数在评估维持性腹膜透析患者营养中的应用[J].医学信息,2021,34(16):47.[doi:10.3969/j.issn.1006-1959.2021.16.013]
　DENG Wen-yi,XU Guo-yu,LIU Guo-hui.Application of Elderly Nutritional Risk Index in Evaluating Nutrition of Maintenance Peritoneal Dialysis Patients[J].Medical Information,2021,34(24):47.[doi:10.3969/j.issn.1006-1959.2021.16.013]
[7]伊丽娜,杨 勤.影响菌群移植效果的因素研究[J].医学信息,2022,35(03):53.[doi:10.3969/j.issn.1006-1959.2022.03.013]
　YI Li-na,YANG Qin.Factors Affecting the Efficacy of Fecal Microbiota Transplantation[J].Medical Information,2022,35(24):53.[doi:10.3969/j.issn.1006-1959.2022.03.013]
[8]赖璐华,李玉兰,黄秋菊,等.有营养风险的2型糖尿病周围神经病变患者的临床特征研究[J].医学信息,2022,35(17):120.[doi:10.3969/j.issn.1006-1959.2022.17.032]
　LAI Lu-hua,LI Yu-lan,HUANG Qiu-ju,et al.Clinical Characteristics of Type 2 Diabetic Peripheral Neuropathy Patients with Nutritional Risk[J].Medical Information,2022,35(24):120.[doi:10.3969/j.issn.1006-1959.2022.17.032]
[9]郭伟强,韦碧柳.溃疡性结肠炎营养诊疗的可视化分析[J].医学信息,2024,37(13):20.[doi:10.3969/j.issn.1006-1959.2024.13.004]
　Visual Analysis of Nutritional Diagnosis and Treatment of Ulcerative Colitis.Visual Analysis of Nutritional Diagnosis and Treatment of Ulcerative Colitis[J].Medical Information,2024,37(24):20.[doi:10.3969/j.issn.1006-1959.2024.13.004]

更新日期/Last Update: 1900-01-01